BBJS Financial Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

BBJS Financial Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$5.12M	Buy	51,839 +33	+0.1%	+$3.24K	1.83%	17
2024 Q2	$4.8M	Buy	51,806 +930	+2%	+$83.4K	1.79%	16
2024 Q1	$4.83M	Buy	50,876 +255	+0.5%	+$23.7K	1.72%	16
2023 Q4	$4.52M	Sell	50,621 -7,189	-12%	-$534K	1.57%	16
2023 Q3	$4.22M	Buy	57,810 +4,832	+9%	+$386K	1.6%	18
2023 Q2	$4.41M	Buy	52,978 +1,973	+4%	+$165K	1.77%	16
2023 Q1	$3.89M	Buy	51,005 +4,440	+10%	+$368K	1.58%	19
2022 Q4	$3.86M	Buy	+46,565	New	+$3.77M	1.74%	17

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

BBJS Financial Advisors's XBI Position: Q3 2024 in Review

BBJS Financial Advisors increased its State Street SPDR S&P Biotech ETF (XBI) stake by 0.06% in Q3 2024, buying an estimated $3.24K and bringing the position to 51,839 shares worth $5.12M. The position accounts for 1.83% of the portfolio, ranked #17.

BBJS Financial Advisors first reported a position in XBI in Q4 2022 and has held it in 8 quarters since. 769 funds tracked by Wall St. Rank hold XBI as of Q3 2024.

BBJS Financial Advisors held 51,839 shares of State Street SPDR S&P Biotech ETF worth $5.12M as of Q3 2024.
BBJS Financial Advisors bought 33 State Street SPDR S&P Biotech ETF shares in Q3 2024, an estimated $3.24K.
State Street SPDR S&P Biotech ETF made up 1.83% of BBJS Financial Advisors's portfolio in Q3 2024, its #17 holding.
BBJS Financial Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q4 2022 and has held it in 8 quarters since.
769 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2024.

Based on BBJS Financial Advisors's 13F filing for Q3 2024, filed 15 Oct 2024.